Michael Bishop to Neurotoxicity Syndromes
This is a "connection" page, showing publications Michael Bishop has written about Neurotoxicity Syndromes.
Connection Strength
0.942
-
Clinical predictors of chimeric antigen receptor T-cell therapy neurotoxicity: a single-center study. Immunotherapy. 2021 10; 13(15):1261-1269.
Score: 0.737
-
Phase 1 study of CART-ddBCMA for the treatment of subjects with relapsed and refractory multiple myeloma. Blood Adv. 2023 03 14; 7(5):768-777.
Score: 0.204